192 related articles for article (PubMed ID: 9688898)
1. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts.
Trueblood N; Ramasamy R
Am J Physiol; 1998 Jul; 275(1):H75-83. PubMed ID: 9688898
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
Ramasamy R; Oates PJ; Schaefer S
Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
[TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion.
Ramasamy R; Trueblood N; Schaefer S
Am J Physiol; 1998 Jul; 275(1):H195-203. PubMed ID: 9688914
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat.
Ramasamy R; Liu H; Oates PJ; Schaefer S
Cardiovasc Res; 1999 Apr; 42(1):130-9. PubMed ID: 10435004
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase activation is a key component of myocardial response to ischemia.
Hwang YC; Sato S; Tsai JY; Yan S; Bakr S; Zhang H; Oates PJ; Ramasamy R
FASEB J; 2002 Feb; 16(2):243-5. PubMed ID: 11772943
[TBL] [Abstract][Full Text] [Related]
6. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor.
Obrosova I; Faller A; Burgan J; Ostrow E; Williamson JR
Curr Eye Res; 1997 Jan; 16(1):34-43. PubMed ID: 9043821
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
8. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.
Beyer-Mears A; Mistry K; Diecke FP; Cruz E
Pharmacology; 1996 May; 52(5):292-302. PubMed ID: 8807673
[TBL] [Abstract][Full Text] [Related]
9. Depletion of phospholipid arachidonoyl-containing molecular species in a human Schwann cell line grown in elevated glucose and their restoration by an aldose reductase inhibitor.
Kuruvilla R; Eichberg J
J Neurochem; 1998 Aug; 71(2):775-83. PubMed ID: 9681469
[TBL] [Abstract][Full Text] [Related]
10. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
Gonzalez AM; Sochor M; Hothersall JS; McLean P
Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
Nakano T; Petrash JM
Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
[TBL] [Abstract][Full Text] [Related]
12. Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration.
Johnson BF; Nesto RW; Pfeifer MA; Slater WR; Vinik AI; Chyun DA; Law G; Wackers FJ; Young LH
Diabetes Care; 2004 Feb; 27(2):448-54. PubMed ID: 14747227
[TBL] [Abstract][Full Text] [Related]
13. Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts.
Li Q; Hwang YC; Ananthakrishnan R; Oates PJ; Guberski D; Ramasamy R
Cardiovasc Diabetol; 2008 Oct; 7():33. PubMed ID: 18957123
[TBL] [Abstract][Full Text] [Related]
14. Glucose dependence of glycolysis, hexose monophosphate shunt activity, energy status, and the polyol pathway in retinas isolated from normal (nondiabetic) rats.
Winkler BS; Arnold MJ; Brassell MA; Sliter DR
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):62-71. PubMed ID: 9008631
[TBL] [Abstract][Full Text] [Related]
15. Myocardial performance and metabolism in non-ketotic, diabetic rat hearts: myocardial function and metabolism in vivo and in the isolated perfused heart under the influence of insulin and octanoate.
Rösen P; Windeck P; Zimmer HG; Frenzel H; Bürrig KF; Reinauer H
Basic Res Cardiol; 1986; 81(6):620-35. PubMed ID: 3545178
[TBL] [Abstract][Full Text] [Related]
16. The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat.
Kamijo M; Cherian PV; Sima AA
Diabetologia; 1993 Oct; 36(10):893-8. PubMed ID: 8243866
[TBL] [Abstract][Full Text] [Related]
17. Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury.
Tracey WR; Magee WP; Ellery CA; MacAndrew JT; Smith AH; Knight DR; Oates PJ
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1447-52. PubMed ID: 11009428
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.
Hwang YC; Shaw S; Kaneko M; Redd H; Marrero MB; Ramasamy R
FASEB J; 2005 May; 19(7):795-7. PubMed ID: 15746188
[TBL] [Abstract][Full Text] [Related]
19. Preferential inhibition of lactate oxidation relative to glucose oxidation in the rat heart following diabetes.
Chatham JC; Gao ZP; Bonen A; Forder JR
Cardiovasc Res; 1999 Jul; 43(1):96-106. PubMed ID: 10536694
[TBL] [Abstract][Full Text] [Related]
20. A 13C-NMR study of glucose oxidation in the intact functioning rat heart following diabetes-induced cardiomyopathy.
Chatham JC; Forder JR
J Mol Cell Cardiol; 1993 Oct; 25(10):1203-13. PubMed ID: 8263954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
